Status:
COMPLETED
Treatment of Androgenic Alopecia in Males
Lead Sponsor:
Lexington International, LLC
Conditions:
Androgenetic Alopecia
Hair Loss
Eligibility:
MALE
25-60 years
Phase:
NA
Brief Summary
The purpose of this study is to evaluate the change in terminal hair count at 16 and 26 weeks compared to baseline measurements.
Detailed Description
This is randomized, double-blind, control device clinical study across 3 sites, evaluating changes in terminal hair-count in the evaluation zone having evidence of androgenetic alopecia (miniaturized ...
Eligibility Criteria
Inclusion
- Diagnosis of androgenetic alopecia
- Fitzpatrick Skin Types I-IV
- Norwood-Hamilton IIa to V
- Active hair loss within last 12 months
Exclusion
- Photosensitivity to laser light
- Malignancy in the target area
Key Trial Info
Start Date :
July 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2010
Estimated Enrollment :
79 Patients enrolled
Trial Details
Trial ID
NCT00947219
Start Date
July 1 2009
End Date
August 1 2010
Last Update
January 31 2013
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Abe Marcadis, M.D.
West Palm Beach, Florida, United States, 33409
2
David Goldberg, M.D.
Hackensack, New Jersey, United States, 07601
3
Zoe Draelos, M.D.
High Point, North Carolina, United States, 27262